Clinical response to mepolizumab in patients with severe eosinophilic asthma

15:30 - 15:45

Speaker: Erin Harvey

Late discontinuation of omalizumab in severe asthma

15:45 - 16:00

Speaker: Matthew Fanning

Serum prednisolone levels as a marker of adherence in severe asthma

16:00 - 16:15

Speaker: James Michael Ramsahai

Efficacy of azithromycin in severe asthma

16:15 - 16:30

Speaker: Peter Gibson

What severe asthma treatment outcomes matter to patients?

16:30 - 16:45

Speaker: Vanessa Clark

Benralizumab improves small airway function rapidly in patients with severe eosinophilic asthma

16:45 - 17:00

Speaker: Tanya Badal